Hassenbusch, MD, PhD PRS Leadership & Institutional Service Award, The University of Texas MD Anderson Cancer Center, 2022 - Present Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2020 - Present Vice-Chair, Institutional Review Board, The University of Texas MD Anderson Cancer Center, 2019 - Present Member, CME Advisory Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019 Member- Division of Cancer Medicine, PRS Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2015 - 2017 Member, Institutional Review Board 5, The University of Texas MD Anderson Cancer Center, 2013 - Present Member, Institutional Research Grant Study Section Review Committee for Clinical Translational and Population-based Research Projects, The University of Texas MD Anderson Cancer Center, 2012 - Present Member, Clinical Research Committee 1, The University of Texas MD Anderson Cancer Center, 2012 - 2014 Associate Member, Institutional Review Board 5, The University of Texas MD Anderson Cancer Center, 2012 - 2013 Committee Chair, Institutional Research Grant Study Section Review Committee for Clinical Translational and Population-based Research Projects, The University of Texas MD Anderson Cancer Center, 2011 - 2012 Member, Institutional Review Board 5, The University of Texas MD Anderson Cancer Center, 2011 - 2012 Vice Chairman, Institutional Research Grant Study Section Review Committee for Clinical Translational and Population-based Research Projects, The University of Texas MD Anderson Cancer Center, 2010 - 2011 Member, Institutional Research Grant Study Section Review Committee for Clinical Translational and Population-based Research Projects, The University of Texas MD Anderson Cancer Center, 2009 - 2010 Member, Clinical Research Committee 4, The University of Texas MD Anderson Cancer Center, 2007 - 2010 Member, Sepsis Order Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2007 Member, Anemia Guidelines Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2007 Editorial Activities Editorial Board Member, Leukemia & Lymphoma, 2021 - Present Editorial Board Member, American Journal of Hematology, 2019 - 2022 Editorial Board Member, Acta Haematologica, 2017 Associate Editor, Frontiers in Hematology Oncology, 2011 Editorial Board Member, Personalized Medicine in Oncology, 2011 Honors & Awards Professional Memberships Society of Hematologic Oncology 2013 - Present Indo-American Cancer Association 2011 - Present Harris County Medical Society 2007 - Present Texas Medical Society 2007 - Present American Association for Cancer Research 2006 - Present American Society of Hematology 2001 - Present American Society of Clinical Oncology 2001 - Present Selected Presentations & Talks Local Presentations 2025
Studies show that improved growth hormone status correlates with better fat metabolism and muscle preservation
Malti N, Merzouk H, Merzouk SA, Loukidi B, Karaouzene N, Malti A, et al
Immune System is at the heart of all immune function
Underserved multiplier means a logistic function applied to the proportion of the hospital's patients with dual eligibility status out of the hospital's total Medicare inpatient population during the calendar year that is 2 years prior to the applicable fiscal year
